Chemotherapy for Inoperable Lung Cancer
Author Information
Author(s): Scinto A F, Ferraresi V, Milella M, Tucci E, Santomaggio C, Pasquali-Lasagni R, Vecchio M R Del, Campioni N, Nardi M, Cognetti F
Primary Institution: Regina Elena Cancer Institute
Hypothesis
The study investigates the effectiveness of the ICE chemotherapy regimen in patients with locally advanced inoperable non-small-cell lung cancer.
Conclusion
The ICE regimen is effective in treating locally advanced non-small-cell lung cancer with manageable toxicity.
Supporting Evidence
- The overall response rate after three chemotherapy courses was 69%.
- Grade 3–4 neutropenia occurred in 21% of evaluable courses.
- Median overall survival for the entire group was 12.5 months.
Takeaway
Doctors tested a special medicine on sick people who couldn't have surgery for their lung cancer, and it helped many of them feel better.
Methodology
Patients received three courses of the ICE chemotherapy regimen and were monitored for responses and side effects.
Limitations
The study had a small sample size and was limited to a specific patient population.
Participant Demographics
Patients included 10 with stage IIIA and 33 with stage IIIB non-small-cell lung cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website